is an advanced stage of prostate cancer High ctDNA% identifies aggressive mCRPC A new tool simplifies ctDNA testing, ensuring timely and accurate prostate cancer management Prostate cancer is the ...

“This is especially true for patients who are positive for circulating tumour DNA (ctDNA), which puts them ... According to Pancreatic Cancer UK, KRAS mutations are the main driver of the ...

Minimal residual disease testing could transform cancer care—personalized therapies, early relapse detection, and improved ...

Researchers report on the development of a novel ctDNA-based liquid biopsy approach, Aneuploidy in Circulating Tumor DNA (ACT-Discover), that identifies subclonal copy number alterations in pancreatic ...

Study: Advances in Screening and Early Diagnosis of Pancreatic Cancer. Image Credit ... like circulating tumor deoxyribonucleic acid (ctDNA), tumor ribonucleic acid (RNA), and exosomes.

The research demonstrates how ctDNA and next-generation sequencing (NGS) can drive more personalized and accurate treatment options for cancer patients. "Our presence at AMP 2024 underscores ...